Benefits of probabilistic sensitivity analysis - a review of NICE decisions
{{output}}
Objective: Since 2004, the National Institute of Health and Clinical Excellence (NICE) has required manufacturers to conduct a probabilistic sensitivity analysis (PSA) in their technology appraisals. The objective of this review ... ...
